Heterozygous BRCA1 and BRCA2 and Mismatch Repair Gene Pathogenic Variants in Children and Adolescents With Cancer.
Christian Peter KratzDmitrii SmirnovRobert AutryNatalie JägerSebastian M WaszakAnika GroßhennigRiccardo BeruttiMareike WendorffPierre HainautStefan M PfisterHolger ProkischTim RippergerDavid MalkinPublished in: Journal of the National Cancer Institute (2022)
These data suggest that heterozygous PVs in BRCA1 and 2 and mismatch repair genes contribute with reduced penetrance to cancer risk in children and adolescents. No changes to predictive genetic testing and surveillance recommendations are required.